GLP-1 therapies are reshaping metabolic care at unprecedented speed — but alongside the headlines, clinicians are left navigating complex questions around long-term outcomes, sustainability, nutrition, and patient dependency.
This thought-leadership evening brings healthcare professionals together to explore how GLP-1s fit into modern metabolic care — without losing sight of physiology, behaviour, and long-term health.
We are delighted to welcome Dr David Unwin as our keynote speaker — a GP, internationally recognised educator, and one of the most trusted clinical voices in metabolic health. Known for his measured, evidence-led approach, Dr Unwin will explore how GLP-1 therapies can be used thoughtfully and responsibly, alongside nutrition-first strategies that protect metabolic resilience, muscle mass, and patient autonomy.
Rather than positioning GLP-1s as a silver bullet — or dismissing them outright — this keynote will challenge clinicians to think critically, ethically, and systemically about where these therapies belong in practice.
Keynote Speaker
Dr David Unwin
GP | International Leader in Metabolic Health
Dr Unwin is widely recognised for his balanced, evidence-based approach to metabolic care. In this keynote, he will explore where GLP-1 therapies sit within modern clinical practice, how nutrition remains foundational, and what sustainable metabolic care looks like beyond short-term interventions.
Spotlight Speaker
Lorna Driver-Davies
Clinical Nutritionist | Wild Nutrition
Session details:
Redefining GLP-1 for Women's Health
Clinical Immuno-Endocrine Applications in Gynaecology
Lorna will forward the compelling concept of the future of immuno-gynaecology, positioning GLP-1 as a sophisticated immunomodulatory tool and hormone modulator with profound implications for women’s health. Beyond glycemic control and weight management, GLP-1 interrupts the cycle of chronic, low-grade inflammation and reduces pro-inflammatory adipokines to offer targeted clinical benefits across gynaecological diseases, conditions, and lifestages. This presentation explores how the systemic regulatory effects of GLP-1 redefine its role from a simple metabolic aid to a crucial intervention for the complex female immune and endocrine landscape.
Spotlight Speaker
Christine Bailey
Award-Winning Nutritionist | Doctor's Data
Inside the GLP-1 Gut
What Stool Testing Reveals About Gastrointestinal Function and Microbial Shifts
In this presentation, Christine explores how GLP-1 therapies reshape gastrointestinal physiology, positioning the gut as a key site of both therapeutic effect and emerging clinical complexity. Moving beyond glycaemic control, she examines the impact of GLP-1 on gastric emptying, migrating motor complex activity, bile flow and gut barrier function — alongside the nuanced shifts observed in microbial ecology.
Drawing on insights from the GI360 stool test, Christine highlights the patterns practitioners are beginning to see in clinical practice, including changes in butyrate production, Akkermansia abundance and microbial diversity. Through a case-based lens, she will outline the key markers to assess, what they may indicate in the context of GLP-1 use, and why functional testing is becoming an increasingly valuable tool in understanding individual responses.
Spotlight Speaker
Lesley Harper
Registered Nutritionist | Invivo
Session details:
Restoring Gut Function on GLP-1
Clinical Strategies to Support Motility, Barrier Integrity and Digestive Resilience
In this presentation, Lesley builds on emerging insights into GLP-1-induced gastrointestinal changes, focusing on how practitioners can respond effectively in clinical practice. Moving beyond mechanism, she explores targeted nutritional and supplemental strategies to support gastric motility, optimise bile flow and restore gut barrier integrity in clients using GLP-1 therapies.
Addressing common clinical presentations, this session will highlight key nutritional considerations, potential deficiencies and practical interventions to mitigate digestive disruption and support long-term gastrointestinal resilience. Designed for clinicians, it provides a clear framework for translating gut-related findings into personalised, actionable support strategies.
Panel Discussion
Following the keynote, an expert panel will broaden the conversation by examining:
-
Alternatives and adjuncts to GLP-1 therapies
-
Nutrition-first approaches to metabolic health
-
Long-term sustainability and patient independence
-
Practical considerations clinicians face in real-world practice
Whats included:
- Access to full event + Q&A
- Bowl food, Snacks, Drinks, and Networking
- Exclusive Sponsor Discounts and goodybag
The evening will then open into an expert panel discussion, bringing together diverse clinical perspectives to explore alternatives, adjuncts, and nutrition-led strategies that support metabolic health beyond pharmacology alone. Together, we’ll examine what sustainable metabolic care really looks like — and how practitioners can design pathways that serve patients long after the prescription ends.
This is not a debate for headlines.
It’s a clinical conversation for clinicians and practitioners shaping the future of metabolic care.
